As of 2025-11-14, the EV/EBITDA ratio of Bolt Biotherapeutics Inc (BOLT) is -0.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BOLT's latest enterprise value is 1.76 mil USD. BOLT's TTM EBITDA according to its financial statements is -51.75 mil USD. Dividing these 2 quantities gives us the above BOLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 16.2x | 15.8x |
| Forward P/E multiples | 17.6x - 30.7x | 22.3x |
| Fair Price | (371.96) - (341.99) | (403.86) |
| Upside | -8014.0% - -7376.3% | -8692.7% |
| Date | EV/EBITDA |
| 2025-11-12 | -0.03 |
| 2025-11-11 | -0.04 |
| 2025-11-10 | -0.04 |
| 2025-11-07 | -0.03 |
| 2025-11-06 | -0.04 |
| 2025-11-05 | -0.04 |
| 2025-11-04 | -0.05 |
| 2025-11-03 | -0.08 |
| 2025-10-31 | -0.08 |
| 2025-10-30 | -0.08 |
| 2025-10-29 | -0.09 |
| 2025-10-28 | -0.08 |
| 2025-10-27 | -0.11 |
| 2025-10-24 | -0.09 |
| 2025-10-23 | -0.08 |
| 2025-10-22 | -0.08 |
| 2025-10-21 | -0.08 |
| 2025-10-20 | -0.09 |
| 2025-10-17 | -0.08 |
| 2025-10-16 | -0.09 |
| 2025-10-15 | -0.09 |
| 2025-10-14 | -0.09 |
| 2025-10-13 | -0.09 |
| 2025-10-10 | -0.09 |
| 2025-10-09 | -0.09 |
| 2025-10-08 | -0.11 |
| 2025-10-07 | -0.10 |
| 2025-10-06 | -0.06 |
| 2025-10-03 | -0.06 |
| 2025-10-02 | -0.05 |
| 2025-10-01 | -0.08 |
| 2025-09-30 | -0.06 |
| 2025-09-29 | -0.06 |
| 2025-09-26 | -0.07 |
| 2025-09-25 | -0.07 |
| 2025-09-24 | -0.08 |
| 2025-09-23 | -0.07 |
| 2025-09-22 | -0.06 |
| 2025-09-19 | -0.06 |
| 2025-09-18 | -0.06 |
| 2025-09-17 | -0.07 |
| 2025-09-16 | -0.05 |
| 2025-09-15 | -0.06 |
| 2025-09-12 | -0.06 |
| 2025-09-11 | -0.06 |
| 2025-09-10 | -0.06 |
| 2025-09-09 | -0.05 |
| 2025-09-08 | -0.06 |
| 2025-09-05 | -0.06 |
| 2025-09-04 | -0.04 |